A major achievement with far-reaching implications for treating deadly skin cancer has been discovered by Tel Aviv University ...
Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...
News-Medical.Net on MSN
Inhalable nanotherapy can activate the immune system against checkpoint-resistant melanoma
Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...
A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...
AZoLifeSciences on MSN
Microneedle patches may unlock safer, localized cancer immunotherapy
This review highlights the potential of natural polysaccharide microneedles in cancer immunotherapy, focusing on localized ...
AZoLifeSciences on MSN
Early disease detection through microbiome biomarkers and sequencing technologies
Microbiome diagnostics and AI are redefining early disease detection, emphasizing the gut's impact on health and the ...
The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...
With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...
-- Proceeds to drive global Phase 3 trial for ASP-1929, targeting BLA submission to the U.S. FDA in 2028 -- Financing led by international life science fund TaiAx, with participation from the largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback